Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 864070 44 0. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116239552B reveals a magnesium-catalyzed route for empagliflozin intermediates. This method offers significant supply chain stability and cost reduction potential for pharmaceutical manufacturing.
Improved empagliflozin synthesis patent CN118271301A offers high purity and cost reduction for pharmaceutical intermediate manufacturing supply chains.
Patent CN109988161A details a telescoped synthesis for Empagliflozin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN119613391B reveals ionic liquid extraction for empagliflozin purification offering high purity yield and reduced solvent consumption for scalable pharmaceutical manufacturing supply chains.